CK 3197;1-Benzoyl-4-ethyl-5-[4-(2-methyl-2-imidazolin-1-yl)benzoyl]-1H-imidazol-2(3H)-one;2H-Imidazol-2-one, 1-benzoyl-5-[4-(4,5-dihydro-2-methyl-1H-imidazol-1-yl)benzoyl]-4-ethyl-1,3-dihydro-
CK-3197 is used as a selective positive inotropic agent for the treatment of congestive heart failure; it exhibits hemodynamic and myocardial energetic effects in vivo.